🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

24+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 4 of 24 recruiting trials for “Paroxysmal nocturnal hemoglobinuria”

Phase 3RecruitingNCT05744921 ↗

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 43 sites📅 Started Mar 2023View details ↗
Phase 3RecruitingNCT05133531 ↗

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 69 sites📅 Started Aug 2022View details ↗
NARecruitingNCT05755867 ↗

Global PNH Patient Registry

👨‍⚕️ Alice Houk, MS, Aplastic Anemia and MDS International Foundation📍 1 site📅 Started May 2021View details ↗
Phase 2RecruitingNCT04901936 ↗

A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

🏥 Apellis Pharmaceuticals, Inc.📍 12 sites📅 Started Feb 2021View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →